Your browser doesn't support javascript.
loading
Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.
Marateb, Hamid Reza; von Cube, Maja; Sami, Ramin; Haghjooy Javanmard, Shaghayegh; Mansourian, Marjan; Amra, Babak; Soltaninejad, Forogh; Mortazavi, Mojgan; Adibi, Peyman; Khademi, Nilufar; Sadat Hosseini, Nastaran; Toghyani, Arash; Hassannejad, Razieh; Mañanas, Miquel Angel; Binder, Harald; Wolkewitz, Martin.
Afiliación
  • Marateb HR; Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan, Iran. h.marateb@eng.ui.ac.ir.
  • von Cube M; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain. h.marateb@eng.ui.ac.ir.
  • Sami R; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Haghjooy Javanmard S; Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mansourian M; Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Amra B; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain. marjan.mansourian@upc.edu.
  • Soltaninejad F; Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran. marjan.mansourian@upc.edu.
  • Mortazavi M; Bamdad Respiratory Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Adibi P; The Respiratory Research Center, Pulmonary Division, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Khademi N; Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Sadat Hosseini N; Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of Medical Sciences, Isfahan, Iran.
  • Toghyani A; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Hassannejad R; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mañanas MA; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Binder H; Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Wolkewitz M; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain.
BMC Med Res Methodol ; 21(1): 146, 2021 07 14.
Article en En | MEDLINE | ID: mdl-34261439
BACKGROUND: Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. METHODS: We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission: sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead. RESULTS: Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC = 0.872 [CI 95%: 0.835-0.910]). CONCLUSIONS: This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: BMC Med Res Methodol Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: BMC Med Res Methodol Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Irán